Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13338378 | 0.94 | ACHE (0.48) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338404 | 0.88 | MAPT (0.43) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338503 | 0.86 | ACHE (0.41) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338389 | 0.86 | ALDH1A1 (0.41) | ACHESLC6A2SLC6A4ARTP53 | |
| SCHEMBL13338373 | 0.85 | AR (0.45) | ACHEARALDH1A1 | |
| SCHEMBL13338574 | 0.84 | MAOA (0.37) | SLC6A2SLC6A4ARTP53MAPT | |
| SCHEMBL22336313 | 0.83 | ACHE (0.38) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338733 | 0.83 | CYP1A2 (0.37) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338746 | 0.82 | HSD17B1 (0.44) | ACHESLC6A2SLC6A4TP53MAPT | |
| SCHEMBL13338748 | 0.82 | KMT2A (0.40) | ACHESLC6A2SLC6A4TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| WO-2020162600-A1 | POLYCYCLIC AROMATIC COMPOUND | 学校法人関西学院 | 2020-08-13 | — | — | WO | disclosed |
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | ACHE 3958/4885SLC6A2 1920/4885SLC6A4 3115/4885 |
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | ACHE 2234/4885SLC6A2 2141/4885SLC6A4 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.